The overexpression of BCAT2 in the human pancreatic cancer cell line Aspc-1 and hepatocellular carcinoma cells HepG2 increased intracellular glutamate and glutamate release, increased system Xc− activity, and inhibited ferroptosis. This evidence concerns the gene BCAT2 and familial pancreatic carcinoma.